A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: A hypothesis

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 7, 2007, Pages 1325-1329

  Mason, Joel B ^a,b   Dickstein, Aaron ^b   Jacques, Paul F ^a   Haggarty, Paul ^c   Selhub, Jacob ^a   Dallal, Gerard ^a   Rosenberg, Irwin H ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ARTICLE; BIOLOGY; COLORECTAL CANCER; HUMAN; HYPOTHESIS; INSTITUTIONAL CARE; OBSERVATIONAL STUDY; PRIORITY JOURNAL;

ANIMALS; CANADA; COLORECTAL NEOPLASMS; FOLIC ACID; FOOD, FORTIFIED; HUMANS; INCIDENCE; NEURAL TUBE DEFECTS; UNITED STATES;

EID: 34447550432     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0329     Document Type: Article

References (40)

1. U.S. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. 21 CFR Parts 136, 137, and 139. Fed Regist 1996;61:8781-807.
2. Health Canada. Regulations amending the Food and Drug Regulations (1066). Canada Gazette, Part I 1997;131:3702-37.
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
4. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
5. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
6. Ray JG. Folic acid food fortification in Canada. Nutr Rev 2004;62:S35-9.
7. Stevenson RE, Allen WP, Pai GS, et al. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 2000;106:677-83.
8. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong L-YC. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
9. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DEC. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002;360:2047-8.
10. Rader JI, Weaver CM, Angyal G. Total folate in enriched cereal-grain products in the United States following fortification. Food Chem 2000;70:275-89.
11. Chen LT, Rivera MA. The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr Rev 2004;62:S40-3.
12. Hertrampf E, Cortés F. Folic acid fortification of wheat flour: Chile. Nutr Rev 2004;62:S44-8.
13. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. N Engl J Med 1999;341:1485-90.
14. Brent RL, Oakley GP, Jr. The folate debate. Pediatrics 2006;117:1418-9.
15. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004;13:511-9.
16. McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene 2004;23:6349-64.
17. Crott J, Mason JB. MTHFR polymorphisms and colorectal neoplasia. In: Ueland P, Rozen R, editors. MTHFR polymorphisms and disease. Georgetown (TX): Landes Bioscience; 2005. p. 179-84.
18. Choi S-W, Mason JB. Folate status: effects on pathways to colorectal carcinogenesis. J Nutr 2002;132:2413-8S.
19. Shpitz B, Bomstein Y, Mekori Y, et al. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am J Surg 1997;174:425-30.
20. Wagner C. Biochemical role of folate in cellular metabolism. In: Bailey L, editor. Folate in health and disease. New York: Marcel Dekker; 1995. p. 23-42.
21. Kelemen LE. The role of folate receptor α in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer 2006;119:243-50.
22. Voeller D, Rahman L, Zajac-Kaye M. Elevated levels of thymidylate synthase linked to neoplastic transformation of mammalian cells. Cell Cycle 2004;3:1005-7.
23. Farber S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood 1949;4:160-7.
24. Heinle RW, Welch AD. Experiments with pteroylglutamic acid and pteroylglutamic acid deficiency in human leukemia [abstract]. J Clin Invest 1948;27:539.
25. Song J, Medline A, Mason JB, Gallinger S, Kim YI. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res 2000;60:5434-40.
26. Song J, Sohn KJ, Medline A, Ash C, Gallinger S, Kim YI. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res 2000;60:3191-9.
27. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas. JAMA 2007;297:2351-9.
28. Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 2004;80:1123-8.
29. Ulrich CM, Potter JD. Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev 2006;15:189-93.
30. Rosenberg IH. Science-based micronutrient fortification: which nutrients, how much, and how to know? Am J Clin Nutr 2005;82:279-80.
31. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2006. Available from: http://www.cdc.gov/BRFSS/.
32. Cram P, Fendrick AM, Inadomi J, Cowen ME, Carpenter D, Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening. Arch Intern Med 2003;163:1601-5.
33. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:946-51.
34. Sweeney MR, McPartlin J, Weir DG, Scott JM. Measurements of subnanomolar concentrations of unmetabolised folic acid in serum. J Chromatogr B 2003;788:187-91.
35. Kelly P, Mc Partlin J, Scott JM. A combined high-performance liquid chromatographic microbiological assay for serum unmetabolised folic acid. Anal Biochem 1996;238:179-83.
36. Sweeney MR, McPartlin J, Weir DJ, Daly L, Scott JM. Post-prandial serum folic acid response to multiple doses of folic acid in fortified bread. Br J Nutr 2006;94:1-8.
37. Sweeney MR, McPartlin J, Scott J. Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health 2007;7:41. Available from: http://www.biomed-central. com/1471-2458/7/41.
38. Radimer K, Bindewald B, Hughes J, et al. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 2004;160:339-49.
39. Troen AM, Mitchell B, Sorensen B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 2006;136:189-94.
40. Janeway CA, Travers P, Walport MJ, Capra JD. Immunobiology: the immune system in health and disease. 4th ed. New York: Elsevier Science Ltd./Garland Publishing; 1999.